Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paula Lizarazo-Guiza
Observed name:
Paula Catalina Lizarazo Guiza
Institution:
AstraZeneca (Mexico)
Observed institution:
AstraZeneca (Mexico)
ORCID:
0009-0009-5812-4237
Observed ORCID:
0009-0009-5812-4237
OpenAlex ID:
A5114577700
Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction
2024
·
Yair González-Tuyub
, Karla González-Iñiguez
, et al.
·
Journal of Asthma and Allergy
·
5
Real word effectiveness of benralizumab in mexican patients with severe eosinophilic asthma: Responders and super-responders
2026
·
Ulises Noel García Ramírez
, Nadia Karina Aguilar Hinojosa
, et al.
·
Revista Alergia México
PDF
Show more works
View as search
Works count:
2
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type
